Patent · US Expired

2',3'-dideoxy-2',3'-didehydro-2'-fluoroarabino-nucleosides

US4973677A · kind A · utility

2Cited by

0References

3Claims

0Family size

Assignee

Bristol-Meyers Company · US

Inventors

Roman Z. Sterzycki · Madison, US
Muzammil M. Mansuri · Lexington, US
John C. Martin · Los Alamos, US

Key dates

Filing date	Jul 11, 1989
Grant date	Nov 27, 1990
Priority date	—
Expiry date	Jul 11, 2009

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

There are disclosed novel 2',3'-dideoxy-2'-fluoronucleosides and 2'-3'-dideoxy-2',3'-didehydro-2'-fluoronucleosides and processes for their preparation. The compounds so produced exhibit therapeutically useful antiviral and, more particularly, anti-HIV effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.